Cargando…

The atrial fibrillation paradox -connecting hypertension to atrial disease and stroke

Detalles Bibliográficos
Autores principales:	Mendys, Phil, Jackson, Larry R., Solimon, Elsayed Z., Howard, George, Ferdinand, Keith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564052/ https://www.ncbi.nlm.nih.gov/pubmed/34755144 http://dx.doi.org/10.1016/j.ajpc.2021.100284

Ejemplares similares

Associations of dietary patterns with risk of incident atrial fibrillation in the REasons for Geographic And Racial Differences in Stroke (REGARDS)
por: Garg, Parveen K., et al.
Publicado: (2023)

Benefits of Emergency Departments’ Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation)
por: Coll-Vinent, Blanca, et al.
Publicado: (2017)

Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin
por: Alberts, Mark, et al.
Publicado: (2020)

Cross-talk between macrophages and atrial myocytes in atrial fibrillation
por: Sun, Zewei, et al.
Publicado: (2016)

Association of hypertension severity and control with risk of incident atrial fibrillation: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study
por: Garg, Parveen K., et al.
Publicado: (2023)

Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation
por: De Marchis, Gian Marco, et al.
Publicado: (2023)

Multiple Blood Biomarkers and Stroke Risk in Atrial Fibrillation: The REGARDS Study
por: Singleton, Matthew J., et al.
Publicado: (2021)

Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure: A Comparative Meta-Analysis
por: Reddin, Catriona, et al.
Publicado: (2021)

Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry
por: Yoshimoto, Takeshi, et al.
Publicado: (2022)

Time Trends in Atrial Fibrillation-Associated Stroke and Premorbid Anticoagulation: Population-Based Study and Systematic Review
por: Yiin, Gabriel S.C., et al.
Publicado: (2019)

Atrial Fibrillation and Stroke Symptoms in the REGARDS Study
por: Reading Turchioe, Meghan, et al.
Publicado: (2022)

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis
por: Zhou, Zien, et al.
Publicado: (2021)

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study
por: Lip, Gregory Y.H., et al.
Publicado: (2018)

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis
por: Wang, Kang-Ling, et al.
Publicado: (2015)

Association of Atrial Fibrillation Without Cardiovascular Comorbidities and Stroke Risk: From the REGARDS Study
por: Singleton, Matthew J., et al.
Publicado: (2020)

Lipids and atrial fibrillation: New insights into a paradox
por: Sagris, Dimitrios, et al.
Publicado: (2022)

Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
por: Mahnkopf, Christian, et al.
Publicado: (2021)

Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study
por: Van Ganse, Eric, et al.
Publicado: (2020)

The Sensitivity of the Method Used to Detect Atrial Fibrillation in Population Studies Affects Group-Specific Prevalence Estimates: Ethnic and Regional Distribution of Atrial Fibrillation in the REGARDS Study
por: Prineas, Ronald J, et al.
Publicado: (2009)

Characteristics of patients presenting to emergency department for primary atrial fibrillation or flutter at an academic medical center
por: Sadaf, Murrium I., et al.
Publicado: (2021)

Atrial fibrillation in the elderly
por: Franken, Roberto A., et al.
Publicado: (2012)

Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
por: Werner, Franziska, et al.
Publicado: (2016)

Renal denervation reduces atrial remodeling in hypertensive rats with metabolic syndrome
por: Selejan, Simina-Ramona, et al.
Publicado: (2022)

Atrial Fibrillation Related and Unrelated Stroke Recurrence Among Ischemic Stroke Patients With Atrial Fibrillation
por: Kim, Bum Joon, et al.
Publicado: (2021)

Rates of Atrial Fibrillation in Black Versus White Patients With Pacemakers
por: Kamel, Hooman, et al.
Publicado: (2016)

Peripheral Arterial Disease and Risk of Atrial Fibrillation and Stroke: The Multi‐Ethnic Study of Atherosclerosis
por: O'Neal, Wesley T., et al.
Publicado: (2014)

Inappropriate mode switch and unwarranted right ventricular pacing during atrial fibrillation: Paradoxical atrial undersensing
por: Hayashi, Katsuhide, et al.
Publicado: (2022)

Management and Prognosis of Acute Stroke in Atrial Fibrillation
por: Hindsholm, Mette F., et al.
Publicado: (2023)

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
por: Reddy, Vivek Y., et al.
Publicado: (2018)

Coding and non-coding variants in the SHOX2 gene in patients with early-onset atrial fibrillation
por: Hoffmann, Sandra, et al.
Publicado: (2016)

Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study
por: Nielsen, Peter Brønnum, et al.
Publicado: (2022)

Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation
por: Patel, Taral K., et al.
Publicado: (2012)

Area Deprivation Index and Oral Anticoagulation in New Onset Atrial Fibrillation
por: Omole, Toluwa D., et al.
Publicado: (2022)

The “Obesity Paradox” in Patients With HFpEF With or Without Comorbid Atrial Fibrillation
por: Guo, Linjuan, et al.
Publicado: (2022)

Obesity Paradox in Atrial Fibrillation and its Relation with the New Oral Anticoagulants
por: Filho, André Inocêncio Novaes Lima, et al.
Publicado: (2022)

Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction
por: Edwards, Jodi D., et al.
Publicado: (2020)

Atrial Fibrillation in Hypertension: Patients’ Characteristics
por: Koutsaki, Styliani, et al.
Publicado: (2018)

Thrombus Migration Paradox in Patients With Acute Ischemic Stroke
por: Alves, Heitor C., et al.
Publicado: (2019)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
por: Nielsen, Peter Brønnum, et al.
Publicado: (2019)

Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis
por: Ivany, Elena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l07k3nvjqnvll2m8pddh0l2b9k